Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Shows a welcome emphasis on evidence
| The first 150 words of the full text of this article appear below. |
The UK government is to be congratulated on
the launch of its new drug strategy,1 but probably not for
the reasons it might expect. The greatest praise is due not so much for
any specific policy proposal
these are rather predictable
but for the
discipline and integrity the government has shown in preparing a
national drug strategy that is more seriously committed to evidence
than to rhetoric. With such a principle established the government is
now well positioned to revise the strategy as new evidence becomes
available and to advance drug policy in a manner similar to the
advancement of evidenced based medicine. In this we hope that the
government will establish the same requirements across all sectors
in
prevention and enforcement as well as in treatment.
In 1997-8 the total government drug related expenditure was estimated
at £1.4 billion ($2.2 billion), 62% of it spent on enforcement activity.1 Yet the
Read all Rapid Responses